Linden Advisors’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Linden Advisors’s Portfolio XAGE Stock Details XAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,500	Closed	-$89.8K	–	283
2024 Q2	$89.8K	Hold	2,500	–	–	﹤0.01%	204
2024 Q1	$173K	Hold	2,500	–	–	﹤0.01%	208
2023 Q4	$257K	Hold	2,500	–	–	﹤0.01%	204
2023 Q3	$243K	Sell	2,500 -25,800	-91%	-$3.89M	﹤0.01%	230
2023 Q2	$8.75M	Hold	28,300	–	–	0.09%	163
2023 Q1	$8.62M	Hold	28,300	–	–	0.09%	144
2022 Q4	$8.42M	Hold	28,300	–	–	0.09%	147
2022 Q3	$8.27M	Hold	28,300	–	–	0.08%	162
2022 Q2	$8.22M	Sell	28,300 -21,200	-43%	-$6.16M	0.08%	165
2022 Q1	$14.5M	Buy	+49,500	New	+$14.3M	0.09%	154

Other funds holding XAGE

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

HSWM

Hubbell Strickland Wealth Management New Orleans, Louisiana $251M AUM 16.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CMU

Carnegie Mellon University Pittsburgh, Pennsylvania $64.3M AUM 35.71% 1-Year Est. Return

Roundview Capital Princeton, New Jersey $1.61B AUM 16.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Linden Advisors's XAGE Position: Q3 2024 in Review

Linden Advisors sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q3 2024, closing a stake of 2,500 shares — an estimated $89.8K sold.

Linden Advisors first reported a position in XAGE in Q1 2022 and held it in 10 quarters. The position peaked at $14.5M in Q1 2022. 21 funds tracked by Wall St. Rank hold XAGE as of Q3 2024.

Linden Advisors reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Linden Advisors sold 2,500 Longevity Health Holdings, Inc. Common Stock shares in Q3 2024, an estimated $89.8K.
Linden Advisors first reported a position in Longevity Health Holdings, Inc. Common Stock in Q1 2022 and held it in 10 quarters.
Linden Advisors's Longevity Health Holdings, Inc. Common Stock position peaked at $14.5M in Q1 2022.
21 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q3 2024.

Based on Linden Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.